首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Urologic oncology-seminars and original investigations

缩写:UROL ONCOL-SEMIN ORI

ISSN:1078-1439

e-ISSN:1873-2496

IF/分区:2.8/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引4576条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Somar Khalil,Marwa Hamdan Somar Khalil
Purpose: In clear cell renal cell carcinoma (ccRCC), stage dominates prognosis, and grading of tubular dedifferentiation depends on observer judgment. We evaluated the Tissue Memory Score (TMS), a continuous measure of re...
Omri Nativ,Timothy Guerard,Adam Williams et al. Omri Nativ et al.
Background: Accurately distinguishing men with clinically significant prostate cancer (csCaP) from those with indolent disease remains challenging. Biomarkers such as the 4Kscore enhance risk stratification and guide biop...
Ryan M Antar,Vincent E Xu,William S Azar et al. Ryan M Antar et al.
Purpose: Intraductal carcinoma of the prostate (IDC-P) is associated with adverse features, yet whether it independently predicts poor outcomes or merely co-segregates with high-grade disease remains unresolved. We evalua...
Steven M Monda,Tobias Else,Alex Zhu et al. Steven M Monda et al.
Approximately 10% to 14% of urothelial cancer patients harbor pathogenic germline variants, rising to 15% to 20% in upper tract urothelial carcinoma (UTUC), where mismatch repair (MMR) gene variants associated with Lynch syndrome are a majo...
Alessandro Bertini,Chiara Re,Lucia Salerno et al. Alessandro Bertini et al.
Background: Sex-related differences in kidney cancer incidence and tumor biology are well established; however, their impact on peri‑operative performance and long-term oncologic outcomes after surgery remains incomplete...
Kento Morozumi,Yasuhiro Nakamura,Masaaki Oikawa et al. Kento Morozumi et al.
Objectives: Radiotherapy (RT) is a standard treatment for localized prostate cancer (CaP); however, reliable biomarkers for predicting biochemical outcomes after RT remain limited. Although genomic BRCA2 alterations have ...
Japneet K Oberoi,Leslie K Ballas,Mark Tyson et al. Japneet K Oberoi et al.
Muscle-invasive bladder cancer (MIBC) is an aggressive malignancy traditionally treated with radical cystectomy (RC) and perioperative systemic therapy. While this approach provides effective oncologic control, RC is associated with signifi...
Zijian Cai,Hongtao Jin,Yepeng Guo et al. Zijian Cai et al.
Background: Penile squamous cell carcinoma (pSCC) severely impairs quality of life, yet reliable prognostic factors for lymph node metastasis (LNM) and survival remain incompletely defined. Existing LNM detection is invas...
Alessio Filianoti,Manuela Costantini,Valeriu Rosca et al. Alessio Filianoti et al.
Background: Bladder cancer (BCa) lacks reliable non-invasive diagnostic tools. Urinary volatile organic compounds (VOCs) have emerged as potential discriminative biomarkers. We evaluated the diagnostic performance of an e...
Mitchell M Huang,Joseph D Nicolas,Ridwan Alam et al. Mitchell M Huang et al.
Background: Increased utilization of prostate magnetic resonance imaging (MRI) over the past decade may have led to a system shift in the patient population selected for radical prostatectomy (RP). We evaluated whether th...